experimental gorup:Camrelizumab 200mg, d1

2 trials

Sponsors

shandong cancer hospital

Conditions

Gastroesophageal junction carcinomaesophageal cancer

Phase 4

Camrelizumab combined with chemotherapy in neoadjuvant treatment of gastroesophageal junction cancer: A single-arm, single-center, exploratory clinical study

RecruitingChiCTR2300068184

shandong cancer hospitalGastroesophageal junction carcinoma

Start: 2022-09-13Updated: 2023-05-15

Camrelizumab combined with chemotherapy in neoadjuvant treatment of esophageal cancer: A single-arm, single-center, exploratory clinical study

RecruitingChiCTR2300068185

shandong cancer hospitalesophageal cancer

Start: 2022-09-23Updated: 2023-05-15

Related Papers

Neoadjuvant therapy of camrelizumab combined with chemotherapy in patients (pts) with resectable esophageal squamous cell cancer (ESCC): A single-center, single-arm, exploratory clinical trial.

Journal of Clinical Oncology2024-06-01